Singapore markets closed

Straits Times Index
3,290.70
+24.75(+0.76%)
Nikkei
38,229.11
+155.13(+0.41%)
Hang Seng
18,963.68
+425.87(+2.30%)
FTSE 100
8,453.27
+71.92(+0.86%)
Bitcoin USD
63,051.81
+2,057.61(+3.37%)
CMC Crypto 200
1,303.56
-54.45(-4.01%)

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

15.21

-1.92

(-11.21%)

At close: 04:00PM EDT

15.33

+0.12

(+0.79%)

After hours:

07:59PM EDT

Loading interactive chart…

Business Wire
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
SAN DIEGO, May 09, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:
Insider Monkey
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 […]
GuruFocus.com
ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
ACADIA Pharmaceuticals showcases a 74% revenue surge and strategic expansions in its Q1 2024 earnings, underlining strong sales and future market plans.